4.3 Article

Late-onset Huntington disease: An Italian cohort

Journal

JOURNAL OF CLINICAL NEUROSCIENCE
Volume 86, Issue -, Pages 58-63

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.jocn.2020.12.025

Keywords

Huntington disease; Late-onset Huntington's disease; Age of onset; Non-pathological allele; CAG 1

Ask authors/readers for more resources

This study compared the clinical-demographic features of Late-onset Huntington's disease (LoHD) patients with Classic-onset patients (CoHD), finding that LoHD patients represented a quarter of the total cases and exhibited clinical features comparable to CoHD subjects. Further studies are needed to evaluate the influence of non-pathological alleles on disease onset.
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by a CAG expansion greater than 35 triplets in the IT-15 gene, with a clinical onset usually in the forties. Late-onset form of HD is defined as disease onset after the age of 59 years. The aim of the present study is to investigate the clinical-demographic features of Late-onset HD population (LoHD) in comparison to Classic-onset patients (CoHD). We analyzed a well-characterized Italian cohort of 127 HD patients, identifying 25.2% of LoHD cases. The mean age of onset was 65.9 and the mean length of pathological allele was 42.2. The 53.1% of LoHD patients had no family history of HD. No significant differences were observed in terms of gender, type of symptoms at disease onset, and clinical performance during the follow-up visits. The non-pathological allele resulted longer among LoHD patients. There is evidence that longer non-pathological allele is associated with a higher volume of basal ganglia, suggesting a possible protective role even in the onset of HD. In conclusion, LoHD patients in this Italian cohort were frequent, representing a quarter of total cases, and showed clinical features comparable to CoHD subjects. Due to the small sample size, further studies are needed to evaluate the influence of non-pathological alleles on disease onset. (C) 2021 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available